Evaluation of HER2 Status by Quantitative RT-PCR with Internal Specimen Quality Controls in Breast Cancer

被引：0
|
作者：
Lin, Y. [1 ]
Yu, R. [2 ]
Hsu, W. [1 ]
Liu, Y. [3 ]
Chiu, K. [2 ]
Yeh, Y. [1 ]
机构：
[1] Gen Biol Corp, Hsinchu, Taiwan
[2] Genet Dev Corp, Lake Bluff, IL USA
[3] Curiemed Corp, Hsinchu, Taiwan
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2016年 / 18卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
S21
引用
收藏
页码：1003 / 1003
页数：1
相关论文
共 50 条
  • [1] Correlation of Hormone Receptor and HER2 Status Between RT-PCR and Immunohistochemistry in Invasive Breast Cancer
    Meindl, Amanda
    Noncent, Edernst
    Finkelman, Brian
    Shen, Tiansheng
    Blanco, Luis
    Siziopikou, K. P.
    Pincus, Jennifer
    LABORATORY INVESTIGATION, 2019, 99
  • [2] Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer
    Cuadros, M.
    Talavera, P.
    Lopez, F. J.
    Garcia-Perez, I.
    Blanco, A.
    Concha, A.
    PATHOBIOLOGY, 2010, 77 (01) : 38 - 45
  • [3] Correlation of Hormone Receptor and HER2 Status Between RT-PCR and Immunohistochemistry in Invasive Breast Cancer
    Meindl, Amanda
    Noncent, Edernst
    Finkelman, Brian
    Shen, Tiansheng
    Blanco, Luis
    Siziopikou, K. P.
    Pincus, Jennifer
    MODERN PATHOLOGY, 2019, 32
  • [4] A comparative assessment of HER2 status in operable breast cancer by real-time RT-PCR and by immunohistochemistry
    Potemski, Piotr
    Pluciennik, Elzbieta
    Bednared, Andrzej K.
    Kusinska, Renata
    Pasz-Walczak, Grazyna
    Jesionek-Kupnicka, Dorota
    Watala, Cezary
    Kordek, Radzislaw
    MEDICAL SCIENCE MONITOR, 2006, 12 (12): : MT57 - MT61
  • [5] Evaluation of HER2/neu status by real-time quantitative PCR in breast cancer
    Kim, YR
    Choi, JR
    Song, KS
    Chong, WH
    Lee, HD
    YONSEI MEDICAL JOURNAL, 2002, 43 (03) : 335 - 340
  • [6] Detection of HER2 Status in Breast Cancer: Comparison of Current Methods with MLPA and Real-time RT-PCR
    Pazhoomand, Reza
    Keyhani, Elahe
    Banan, Mehdi
    Najmabadi, Hossein
    Karimlou, Masoud
    Khodadadi, Faranak
    Iraniparast, Alireza
    Feiz, Farnaz
    Majidzadeh-A, Keivan
    Bahman, Ideh
    Moghadam, Fatemeh Aghakhani
    Sobhani, Atoosa Madadkar
    Abedini, Seyedeh Sedigheh
    Muhammadnejad, Ahad
    Behjat, Farhondeh
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (12) : 7621 - 7628
  • [7] Study of Concordance between RT-PCR and Immunohistochemical Testing of Hormone Receptor and HER2 Status in Breast Cancer Specimens
    Mehta, R.
    Jain, R. K.
    Sojitra, P. M.
    Gokmen-Polar, Y.
    Badve, S.
    LABORATORY INVESTIGATION, 2011, 91 : 54A - 54A
  • [8] Comparison of immunohistochemistry (IHC) and quantitative RT-PCR: ER, PR, and HER2 receptor status.
    Christopherson, Cindy
    Chang, Monica
    Eberhard, David A.
    Sninsky, John J.
    Anderson, Steven M.
    Wang, Alice M.
    Kwok, Shirley
    Calhoun, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [9] Evaluation of a quantitative RT-PCR assay to detect HER2 mRNA overexpression for diagnosis and selection of trastuzumab therapy in breast cancer tissue samples
    Wang, Hye-young
    Kim, Sunghyun
    Park, Sangjung
    Kim, Seungil
    Jung, Dongju
    Park, Kwang Hwa
    Lee, Hyeyoung
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 97 (03) : 368 - 374
  • [10] Quantitative PCR and HER2 testing in breast cancer
    Barberis, Massimo
    Pellegrini, Caterina
    Cannone, Maria
    Arizzi, Carmelo
    Coggi, Guido
    Bosari, Silvano
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (04) : 563 - 570
12345